FB-15 inhibits MGC-803 cells growth by regulating energy metabolism.

In this study, we scrutinized the anticancer effects of FB-15 on human gastric carcinoma MGC-803 cells in vitro and vivo, and its preliminary effect on tubulin and HIF-1α. We confirmed that FB-15 not only inhibited the proliferation of a large number of cells in a concentration and time-dependent manner but also inhibited proliferation of a single cell to form clones. FB-15 manifested little cytotoxicity for normal stomach cells GES-1. The flow cytometry analysis displayed that FB-15 induced apoptosis MGC-803 cells and mainly arrested cells in the S phase in a concentration-dependent manner. The results of the wound healing assay indicated that FB-15 suppressed cell migration. Furthermore, the western blotting showed that FB-15 down-regulated the expression of β3-tubulin and HIF-1α, consistent with Immunohistochemical assay. The binding modes of FB-15 with tubulin were clarified by molecular docking. FB-15 significantly suppressed the growth of MGC-803 gastric cancer tumors. The inhibitory effect of FB-15 on tumor growth was superior to 5-Fu. Taken together, these results provided evidence for FB-15 to be used as an effective anticancer drug candidate for gastric cancer.

• Publication year

  2020

• Venue

  Chemico-Biological Interactions

• Publication date

  2020-06-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cbi.2020.109186PMID 32590071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration.

  2018cited by this paper
• Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.

  2018cited by this paper
• Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.

  2018cited by this paper
• Design, synthesis and biological evaluation of 3',4',5'-trimethoxy flavonoid benzimidazole derivatives as potential anti-tumor agents.

  2018cited by this paper
• Gastric Cancer as Preventable Disease

  2017cited by this paper
• Design, synthesis and biological evaluation of flavonoid salicylate derivatives as potential anti-tumor agents

  2017cited by this paper
• Gen‐27, a newly synthesized flavonoid, inhibits glycolysis and induces cell apoptosis via suppression of hexokinase II in human breast cancer cells

  2017cited by this paper
• Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death

  2017cited by this paper
• Recent discoveries of anticancer flavonoids.

  2017cited by this paper
• Cancer statistics in China, 2015

  2016cited by this paper
• The hypoxic tumor microenvironment: A driving force for breast cancer progression.

  2016cited by this paper
• Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth.

  2016cited by this paper
• α-Solanine inhibits vascular endothelial growth factor expression by down-regulating the ERK1/2-HIF-1α and STAT3 signaling pathways.

  2016cited by this paper
• Role of HIF-1 on phosphofructokinase and fructose 1, 6-bisphosphatase expression during hypoxia in the white shrimp Litopenaeus vannamei.

  2016cited by this paper
• Superiority of the Ratio Between Negative and Positive Lymph Nodes for Predicting the Prognosis for Patients With Gastric Cancer

  2015cited by this paper
• The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells

  2015cited by this paper
• Natural Compounds Regulate Glycolysis in Hypoxic Tumor Microenvironment

  2015cited by this paper
• Modulation of the tumor vasculature and oxygenation to improve therapy.

  2015cited by this paper
• The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.

  2015cited by this paper
• Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation

  2015cited by this paper
• Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.

  2015cited by this paper
• Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts.

  2015cited by this paper
• The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer

  2014cited by this paper
• Impact of extranodal extension on prognosis in lymph node‐positive gastric cancer

  2014cited by this paper
• Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography

  2014cited by this paper
• Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma

  2014cited by this paper
• In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways

  2014cited by this paper
• Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin/docetaxel or carboplatin/paclitaxel in patients with advanced solid tumors

  2014cited by this paper
• CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model

  2014cited by this paper
• Recent agents targeting HIF‐1α for cancer therapy

  2013cited by this paper
• Natural products: a continuing source of novel drug leads.

  2013cited by this paper
• Vascular-disrupting agents in oncology

  2013cited by this paper
• Treatment with transcatheter arterial chemoembolization induces an increase of the L-selectinlow CXCR3+ CD8+ T cell subset in patients with hepatocellular carcinoma

  2012cited by this paper
• Natural products for cancer chemotherapy

  2011cited by this paper
• Regulation of metabolism by hypoxia-inducible factor 1.

  2011cited by this paper
• Scratch-wound assay.

  2011cited by this paper
• Tumor vasculature as target for therapeutic intervention

  2010cited by this paper
• Zinc Downregulates HIF-1α and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo

  2010cited by this paper
• Cancer proliferation and therapy: the Warburg effect and quantum metabolism

  2010cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Silibinin inhibits hypoxia-inducible factor-1α and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy

  2009cited by this paper
• Impact of natural products on developing new anti-cancer agents.

  2009cited by this paper
• Targeting the hypoxia-inducible factor (HIF) pathway in cancer

  2009cited by this paper
• Methylalpinumisoflavone Inhibits Hypoxia-inducible Factor-1 (HIF-1) Activation by Simultaneously Targeting Multiple Pathways*

  2009cited by this paper
• Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells

  2008cited by this paper
• Inhibition of HIF‐1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3‐M cells

  2008cited by this paper
• Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity.

  2008cited by this paper
• Flavonoids induce HIF-1α but impair its nuclear accumulation and activity

  2008cited by this paper
• Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis.

  2007cited by this paper
• Chrysin inhibits expression of hypoxia-inducible factor-1α through reducing hypoxia-inducible factor-1α stability and inhibiting its protein synthesis

  2007cited by this paper
• Vascular disrupting agents: a new class of drug in cancer therapy.

  2005cited by this paper
• Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy.

  2005cited by this paper
• Disrupting tumour blood vessels

  2005cited by this paper
• Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways

  2005cited by this paper
• Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain

  2004cited by this paper
• Vascular‐targeting therapies for treatment of malignant disease

  2004cited by this paper
• Vascular targeting agents

  2004cited by this paper
• Flavopiridol, An Inhibitor of Transcription: Implications, Problems and Solutions

  2004cited by this paper
• Vascular Targeting Agents as Cancer Therapeutics

  2004cited by this paper
• Molecular aspects of the mammalian cell cycle and cancer.

  2002cited by this paper
• The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells.

  2002cited by this paper
• Activity of the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate in a Xenograft Model of AIDS-Associated Kaposi's Sarcoma

  2002cited by this paper
• The biology of the combretastatins as tumour vascular targeting agents

  2002cited by this paper
• Mapping the Binding Site of Colchicinoids on β-Tubulin

  2000cited by this paper
• Mapping the binding site of colchicinoids on beta -tubulin. 2-Chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354.

  2000cited by this paper
• Oxidative stress contributes to the anti-proliferative effects of flavone acetic acid on endothelial cells.

  2000cited by this paper
• Colchicine: 1998 update.

  1998cited by this paper
• Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.

  1998cited by this paper
• Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

  1997cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Garlic and its significance for the prevention of cancer in humans: a critical view.

  1993cited by this paper
• Colchicine and its analogues: Recent findings

  1988cited by this paper

• Flavonoid derivative FB-15 inhibits the progression of nasopharyngeal carcinoma by targeting the PI3K-Akt signaling pathway.

  2025cites this paper
• Discovery of novel flavonoid derivatives targeting VEGFR2 and tubulin with potent anticancer efficacy.

  2025cites this paper
• Discovery of novel chalcone derivatives containing benzimidazole possessing anti-tumor potential in vitro and in vivo.

  2025cites this paper
• A Smart CA IX-Targeting and pH-Responsive Nano-Mixed Micelles for Delivery of FB15 with Superior Anti-Breast Cancer Efficacy

  2024influential citation
• Design, synthesis, and antitumor evaluation of trimethoxyflavonoid with arylurea structure against hepatocellular carcinoma

  2023cites this paper
• Synthesis and anti-hepatocellular carcinoma evaluation of salicylic acid-modified indole trimethoxy flavonoid derivatives.

  2023cites this paper